Valuation: ICON Public Limited Company

Capitalization 11.69B 10.1B 9.51B 8.6B 15.92B 1,001B 17.93B 110B 43.13B 460B 43.85B 42.93B 1,680B P/E ratio 2025 *
15.8x
P/E ratio 2026 * 13.7x
Enterprise value 14.28B 12.33B 11.61B 10.51B 19.44B 1,223B 21.89B 135B 52.68B 562B 53.56B 52.43B 2,052B EV / Sales 2025 *
1.8x
EV / Sales 2026 * 1.65x
Free-Float
99.29%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.06%
1 week+9.10%
Current month+12.90%
1 month+4.90%
3 months-19.79%
6 months-30.23%
Current year-29.86%
More quotes
1 week 138.59
Extreme 138.59
150
1 month 125.1
Extreme 125.1
150
Current year 125.1
Extreme 125.1
228.28
1 year 125.1
Extreme 125.1
347.72
3 years 125.1
Extreme 125.1
347.72
5 years 125.1
Extreme 125.1
347.72
10 years 62.31
Extreme 62.31
347.72
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 28/02/2017
Director of Finance/CFO 52 30/09/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 31/10/2002
Chairman 62 28/02/2017
Director/Board Member 64 24/11/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.06%+9.10%-54.00%-32.91% 11.57B
+1.11%+3.88%+20.26%+7.44% 49.72B
+0.19%+7.98%-26.82%-23.26% 27.48B
+1.05%+4.51%-4.60%+16.70% 26.19B
+1.34%+6.07%+9.10%-27.57% 12.3B
+0.64%+21.43% - - 12.25B
-1.44%+4.71%-81.49%-78.48% 10.73B
-0.47%-3.73%+30.20%+106.47% 10.37B
+1.43%+4.02%+4.17%-0.42% 10.12B
+0.56%+3.55%-24.70%+118.69% 8.69B
Average +0.47%+4.20%-14.21%+9.63% 17.94B
Weighted average by Cap. +0.63%+4.30%-6.56%+4.41%
See all sector performances

Financials

2025 *2026 *
Net sales 7.95B 6.87B 6.47B 5.85B 10.82B 681B 12.19B 75.13B 29.33B 313B 29.82B 29.19B 1,142B 8.1B 7B 6.59B 5.96B 11.03B 693B 12.42B 76.53B 29.88B 319B 30.38B 29.74B 1,164B
Net income 754M 652M 614M 555M 1.03B 64.61B 1.16B 7.13B 2.78B 29.68B 2.83B 2.77B 108B 819M 708M 667M 603M 1.12B 70.18B 1.26B 7.74B 3.02B 32.24B 3.07B 3.01B 118B
Net Debt 2.59B 2.24B 2.1B 1.9B 3.52B 222B 3.97B 24.45B 9.55B 102B 9.71B 9.5B 372B 1.67B 1.44B 1.36B 1.23B 2.27B 143B 2.56B 15.79B 6.16B 65.73B 6.27B 6.14B 240B
More financial data * Estimated data
Logo ICON Public Limited Company
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Employees
41,250
More about the company
Date Price Change Volume
12/06/25 147.09 $ +1.06% 908,452
11/06/25 145.54 $ +0.56% 1,619,337
10/06/25 144.73 $ +3.59% 1,011,513
09/06/25 139.71 $ +0.43% 1,083,111
06/06/25 139.11 $ +3.18% 980,388

Delayed Quote Nasdaq, June 12, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
147.09USD
Average target price
177.53USD
Spread / Average Target
+20.70%
Consensus

Quarterly revenue - Rate of surprise